The many activities of the company include, but are not limited to:
Clinical development plans
Study design and protocols
Study reports
INDs
NDAs
OTC switches
Due diligence
Expert opinion in legal cases
In addition to its president, Peter U. Feig, MD, PF Pharmaceutical Development
works with several expert associates and in close association with other
consulting companies.
